Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    "Hemoglobin C disease"
Show Display Options
Download search resultsDownload the search results for:
"Hemoglobin C disease" (5 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Withdrawn Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis
Conditions: Anemia, Sickle Cell;   Sickle Cell Anemia;   Sickle Cell Disease;   Sickle Cell Disorders;   Hemoglobin SC Disease;   Sickle Cell Hemoglobin C Disease
Interventions: Drug: MP4CO;   Drug: Sodium chloride solution
2 Terminated
Has Results
Treatment of Sickle Cell Anemia With Stem Cell Transplant
Conditions: Sickle Cell Anemia;   Sickle Cell-hemoglobin C Disease;   Sickle Cell-β0-thalassemia
Interventions: Drug: Fludarabine;   Drug: Cytarabine;   Device: Cellular Infusions;   Radiation: Total Body Irradiation;   Drug: Cyclophosphamide;   Drug: Bortezomib;   Drug: Rituximab;   Procedure: Plasmapheresis
3 Completed Safety Study of MP4CO in Adult Sickle Cell Patients
Conditions: Anemia, Sickle Cell;   Sickle Cell Anemia;   Sickle Cell Disease;   Sickle Cell Disorders;   Hemoglobin SC Disease;   Sickle Cell Hemoglobin C Disease
Interventions: Drug: MP4CO;   Drug: Sodium chloride solution
4 Unknown  Far Infrared Radiation for Sickle Cell Pain Management
Condition: Anemia, Sickle Cell
Intervention: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
5 Completed
Has Results
Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies
Conditions: Hemoglobinopathies;   Sickle Cell Disease;   Thalassemia
Interventions: Drug: Busulfex;   Drug: Fludarabine;   Drug: Alemtuzumab;   Procedure: Stem Cell Transfusion

Indicates status has not been verified in more than two years